pinguecula.
Conditions
Interventions
Intervention group: After all the patients underwent ligation and were divided into two intervention and control groups. In both groups, Pinguecula base ligation was performed, but only in the interve
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patient with pinguecula withouth xerophthalmia and eye surgery withouth diabetes and pregnancy and allergy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The size of the horizontal surface of Pinguecula. Timepoint: Before the start of the study/one week/one month/3 months and six months after ligation and bevacizumab injection. Method of measurement: Quantitative measurement by slit lamp device and its qualitative grading. | — |
Secondary
| Measure | Time frame |
|---|---|
| The degree of inflammation and hyperemia. Timepoint: Before the start of the study/one week/one month/3 months and six months after ligation and bevacizumab injection. Method of measurement: Quantitative measurement by slit lamp device and its qualitative grading. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohadese Sarabadani
Mazandaran University of Medical Sciences
Outcome results
None listed